Sativa Wellness Group Inc.

AQSE Growth Market -
Sativa Wellness (Canadian Securities Exchange: SWEL), is an established therapeutic life science company operating in the UK and Europe. With world-class extraction and formulation experts, along with laboratory testing capabilities, the group has established itself globally as a trusted source of high-grade, compliant, premium wholesale and retail CBD brands through a fully integrated European seed to consumer CBD offering. In addition, the group has added to its wellness portfolio a sanitiser range and an expanding network of UK COVID-19 testing clinics offering high quality services to businesses and individuals.
Symbol Ccy Code Bid Ask Mid Previous Close Volume Last Traded
SWEL GBX 3.8 4 3.9 3.9 142679 30.07.21

MiFID II compliant pre- and post-trade transaction data is available here. The data is delayed by at least 15 minutes and will be refreshed every 15 minutes. Publication of trades in equity securities that are large in scale compared to normal market size and illiquid non-equity securities may be delayed if the trade is eligible for deferred publication in accordance with the trading rules of Aquis Stock Exchange and MiFIR. Further details as to when the publication of a trade may be deferred are set out in the trading rules which are available here.

Key Information

  
Market Cap: £14.22m
ISIN:CA80403E1043
Par:
Inst Type:Ordinaries
Symbol:SWEL
MIFID Status:MTF
Tradable securities in issue:364,615,913
Sector:Pharmaceuticals & Biotechnology
Last results date:31.12.20
% price change since listing:-13.33%
% daily price change:0.00%

Latest Trades

Date & Time Volume Price
30.07.21  |  16:27:451282053.9
30.07.21  |  08:25:5324953.9
30.07.21  |  08:25:37119793.9
27.07.21  |  08:28:32253093.9
26.07.21  |  14:00:36155983.9
22.07.21  |  11:36:50250003.9
21.07.21  |  12:55:513833.9
19.07.21  |  15:36:21254444
16.07.21  |  10:12:37150004
12.07.21  |  14:07:2026374

Latest Announcements

Date & Time Title
23.07.21  |  16:30:00Sativa Wellness - Strategic Update and Strong Trading Position
12.07.21  |  07:00:00Sativa Wellness - Director Option Grant and Grant of Warrants
22.06.21  |  07:00:00Sativa Wellness - 40th clinic opening and listing on Patient Access
09.06.21  |  07:00:00Sativa Wellness - Paper - Cannabinoids Effect on lung inflammation
02.06.21  |  11:24:00Sativa Wellness - Total Voting Rights
25.05.21  |  12:15:00Sativa Wellness - Filing of Q1 2021 Financial Statements
21.05.21  |  07:00:00Sativa Wellness - Closing Final Tranche of Private Placement
04.05.21  |  07:00:00Sativa Wellness - Audited Results to 31 December 2020
28.04.21  |  07:00:00Sativa Wellness - Key Board Appointments
21.04.21  |  07:00:00Sativa Wellness - Laboratory achieves ISO17025 Accreditation

Financial Information

Click here to download a glossary of terms.

All data provided by Fregnan.

31.12.20
Enterprise Value £14.57m
EV/EBITDA (3.19)
EV/EBIT (2.89)
   
PE Ratio (1.45)
PEG -
Dividend Yield -
Free Cash Yield (37.96)%

Click here to download a glossary of terms.

All data provided by Fregnan.

31.12.19
(£'000)
31.12.20
(£'000)
Income Statement    
Revenue 1,4491,994
Operating Income (EBIT) (3,553)(5,042)
Net Income (3,798)(4,659)
     
Balance Sheet    
Cash 1,9931,289
Total Debt 621500
Total Liabilities 1,0501,925
Total Equity 3,5016,284
     
Operating Margin (245.12)%(252.85)%
EPS - Basic (4.77)p(2.87)p
EPS - Growth -(39.88)%
Dividend Per Share --
Average Shares Outstanding 79.60m162.45m
     
ROA -(73.01%)
ROCE -(94.08%)
ROE -(95.22%)

Click here to download a glossary of terms.

All data provided by Fregnan.

31.12.19
(£'000)
31.12.20
(£'000)
Revenue 1,4491,994
Cost of Revenue 695871
Depreciation & Amortisation 260471
Gross Profit 495652
Other Operating Expenses 4,0485,695
Operating Income (EBIT) (3,553)(5,042)
Net Interest Expense 11-
Unusual Expense (incl. Exceptionals) 233(48)
Non-Operating Expense -208
Profit (pre-tax) (3,798)(4,787)
Taxation -128
Other Expenses and Minortity Interest --
Net Income (3,798)(4,659)

Click here to download a glossary of terms.

All data provided by Fregnan.

31.12.19
(£'000)
31.12.20
(£'000)
Cash from Operations (2,613)(2,348)
Cash from Investing (493)2,412
Cash from Financing 1,356(184)
Other Miscellaneous --
Net Cash Flow (1,750)(120)

Click here to download a glossary of terms.

All data provided by Fregnan.

31.12.19
(£'000)
31.12.20
(£'000)
Current Assets 2,7002,888
Non-Current Assets 1,8515,321
Total Assets 4,5528,210
Current Liabilities 6001,442
Non-Current Liabilities 451483
Total Liabilities 1,0501,925
Net Assets 3,5016,284
Total Equity 3,5016,284

Click here to download a glossary of terms.

All data provided by Fregnan.

Address

Business Address

Sativa Wellness Group Inc., Suite 503 – 905, West Pender Street, Vancouver, British Columbia, V6C 1L6, Canada.

Email: enquiries@sativawellnessgroup.com

Phone: +44 (0) 20 7971 1255

Registered Address

SUITE 409 - 221, West Esplanade, North Vancouver, BC, V7M 3J3, CANADA.

Contacts

Corporate Adviser

Peterhouse Capital Ltd, 3rd Floor, 80 Cheapside, London, United Kingdom.

Email: info@pcorpfin.com

Phone: +44 (0)20 7469 0930

Registrar

Computershare Investor Services PLC, The Pavilions, Bridgwater Road, Bristol, BS13 8AE, United Kingdom.

Email: web.queries@computershare.co.uk

Phone: 0370 703 6191